63255 Efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis across different regions of China: a post-hoc analysis of a phase III, randomized controlled trial

Authors
Category Primary study
ConferenceJournal of the American Academy of Dermatology
Year 2025
This article has no abstract
Epistemonikos ID: 5e0846e054b359a937cdf0ccd0a700597160405b
First added on: Apr 29, 2026